메뉴 건너뛰기




Volumn 14, Issue 9, 2014, Pages 1-15

Glucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials

Author keywords

Cardiovascular autonomic neuropathy; Clinical trials; Diabetic neuropathy; Distal symmetrical sensorimotor polyneuropathy; Glucose control

Indexed keywords

GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; GLUCOSE BLOOD LEVEL;

EID: 84957429954     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0528-7     Document Type: Review
Times cited : (211)

References (63)
  • 2
    • 78651101592 scopus 로고    scopus 로고
    • Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments
    • PID: 20876709
    • Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33:2285–93.
    • (2010) Diabetes Care , vol.33 , pp. 2285-2293
    • Tesfaye, S.1    Boulton, A.J.2    Dyck, P.J.3    Freeman, R.4    Horowitz, M.5    Kempler, P.6
  • 3
    • 80053580486 scopus 로고    scopus 로고
    • Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27. Discusses updates on diagnostic criteria for severity of diabetic polyneuropathies
    • Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW. Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. 2011;27. Discusses updates on diagnostic criteria for severity of diabetic polyneuropathies.
  • 4
    • 0025952788 scopus 로고
    • The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus
    • COI: 1:STN:280:DyaK387itVaqsA%3D%3D, PID: 1769441
    • Ziegler D, Mayer P, Muhlen H, Gries FA. The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1991;34:822–9.
    • (1991) Diabetologia , vol.34 , pp. 822-829
    • Ziegler, D.1    Mayer, P.2    Muhlen, H.3    Gries, F.A.4
  • 5
    • 0024424273 scopus 로고
    • Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study
    • COI: 1:STN:280:DyaK3c7lt1Wktg%3D%3D, PID: 2620781
    • Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989;38:1456–61.
    • (1989) Diabetes , vol.38 , pp. 1456-1461
    • Maser, R.E.1    Steenkiste, A.R.2    Dorman, J.S.3    Nielsen, V.K.4    Bass, E.B.5    Manjoo, Q.6
  • 6
    • 0030983181 scopus 로고    scopus 로고
    • Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study
    • COI: 1:STN:280:DyaK2szkslSqsA%3D%3D, PID: 9203456
    • Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study. Diabetes Care. 1997;20:1162–7.
    • (1997) Diabetes Care , vol.20 , pp. 1162-1167
    • Adler, A.I.1    Boyko, E.J.2    Ahroni, J.H.3    Stensel, V.4    Forsberg, R.C.5    Smith, D.G.6
  • 8
    • 0030052838 scopus 로고    scopus 로고
    • Relation of glycemic control to diabetic microvascular complications in diabetes mellitus
    • COI: 1:STN:280:DyaK287kslahtg%3D%3D, PID: 8554220
    • Klein R, Klein BE, Moss SE. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med. 1996;124:90–6.
    • (1996) Ann Intern Med , vol.124 , pp. 90-96
    • Klein, R.1    Klein, B.E.2    Moss, S.E.3
  • 9
    • 0027275397 scopus 로고
    • The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
    • COI: 1:STN:280:DyaK3szgvFGisg%3D%3D, PID: 8147960
    • Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993;329:304–9.
    • (1993) N Engl J Med , vol.329 , pp. 304-309
    • Reichard, P.1    Nilsson, B.Y.2    Rosenqvist, U.3
  • 10
    • 0028357306 scopus 로고
    • The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study
    • COI: 1:STN:280:DyaK2M%2FhtFWisA%3D%3D, PID: 7926342
    • Amthor KF, Dahl-Jorgensen K, Berg TJ, Heier MS, Sandvik L, Aagenaes O, et al. The effect of 8 years of strict glycaemic control on peripheral nerve function in IDDM patients: the Oslo Study. Diabetologia. 1994;37:579–84.
    • (1994) Diabetologia , vol.37 , pp. 579-584
    • Amthor, K.F.1    Dahl-Jorgensen, K.2    Berg, T.J.3    Heier, M.S.4    Sandvik, L.5    Aagenaes, O.6
  • 11
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group
    • DCCT: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–86.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 12
    • 0029558663 scopus 로고
    • Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial
    • DCCT: Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial. Ann Neurol. 1995;38:869–80.
    • (1995) Ann Neurol , vol.38 , pp. 869-880
  • 13
    • 77954966171 scopus 로고    scopus 로고
    • Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study
    • COI: 1:CAS:528:DC%2BC3cXnsFylsbk%3D, PID: 20150297
    • Albers JW, Herman WH, Pop-Busui R, Feldman EL, Martin CL, Cleary PA, et al. Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study. Diabetes Care. 2010;33:1090–6.
    • (2010) Diabetes Care , vol.33 , pp. 1090-1096
    • Albers, J.W.1    Herman, W.H.2    Pop-Busui, R.3    Feldman, E.L.4    Martin, C.L.5    Cleary, P.A.6
  • 14
    • 0031029435 scopus 로고    scopus 로고
    • Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study
    • COI: 1:STN:280:DyaK2s3gtlyjuw%3D%3D, PID: 9051381
    • Sands ML, Shetterly SM, Franklin GM, Hamman RF. Incidence of distal symmetric (sensory) neuropathy in NIDDM. The San Luis Valley Diabetes Study. Diabetes Care. 1997;20:322–9.
    • (1997) Diabetes Care , vol.20 , pp. 322-329
    • Sands, M.L.1    Shetterly, S.M.2    Franklin, G.M.3    Hamman, R.F.4
  • 15
    • 36749096903 scopus 로고    scopus 로고
    • Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes
    • COI: 1:CAS:528:DC%2BD1cXkslyiuw%3D%3D, PID: 17354257
    • Chao CC, Hsieh SC, Yang WS, Lin YH, Lin WM, Tai TY, et al. Glycemic control is related to the severity of impaired thermal sensations in type 2 diabetes. Diabetes Metab Res Rev. 2007;23:612–20.
    • (2007) Diabetes Metab Res Rev , vol.23 , pp. 612-620
    • Chao, C.C.1    Hsieh, S.C.2    Yang, W.S.3    Lin, Y.H.4    Lin, W.M.5    Tai, T.Y.6
  • 16
    • 77958586755 scopus 로고    scopus 로고
    • Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis
    • COI: 1:CAS:528:DC%2BC3cXhsF2gu77F, PID: 20950385
    • Perkins BA, Dholasania A, Buchanan RA, Bril V. Short-term metabolic change is associated with improvement in measures of diabetic neuropathy: a 1-year placebo cohort analysis. Diabet Med. 2010;27:1271–9.
    • (2010) Diabet Med , vol.27 , pp. 1271-1279
    • Perkins, B.A.1    Dholasania, A.2    Buchanan, R.A.3    Bril, V.4
  • 17
    • 0029147687 scopus 로고
    • Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin- dependent diabetes mellitus: a randomized prospective 6-year study
    • COI: 1:CAS:528:DyaK2MXpsVWgtrs%3D, PID: 7587918
    • Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin- dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–17.
    • (1995) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3    Miyata, T.4    Isami, S.5    Motoyoshi, S.6
  • 18
    • 0032511583 scopus 로고    scopus 로고
    • Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group
    • UKPDS: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–53
    • (1998) Lancet , vol.352 , pp. 837-853
  • 19
    • 0033549918 scopus 로고    scopus 로고
    • The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM)
    • COI: 1:STN:280:DC%2BD3c3ivFGjug%3D%3D, PID: 10765007
    • Azad N, Emanuele NV, Abraira C, Henderson WG, Colwell J, Levin SR, et al. The effects of intensive glycemic control on neuropathy in the VA cooperative study on type II diabetes mellitus (VA CSDM). J Diabetes Complications. 1999;13:307–13.
    • (1999) J Diabetes Complications , vol.13 , pp. 307-313
    • Azad, N.1    Emanuele, N.V.2    Abraira, C.3    Henderson, W.G.4    Colwell, J.5    Levin, S.R.6
  • 20
    • 58149389215 scopus 로고    scopus 로고
    • Glucose control and vascular complications in veterans with type 2 diabetes
    • COI: 1:CAS:528:DC%2BD1MXnsFWkug%3D%3D, PID: 19092145
    • Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.
    • (2009) N Engl J Med , vol.360 , pp. 129-139
    • Duckworth, W.1    Abraira, C.2    Moritz, T.3    Reda, D.4    Emanuele, N.5    Reaven, P.D.6
  • 21
    • 84860789015 scopus 로고    scopus 로고
    • Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study
    • PID: 21816977
    • Charles M, Ejskjaer N, Witte DR, Borch-Johnsen K, Lauritzen T, Sandbaek A. Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study. Diabetes Care. 2011;34:2244–9.
    • (2011) Diabetes Care , vol.34 , pp. 2244-2249
    • Charles, M.1    Ejskjaer, N.2    Witte, D.R.3    Borch-Johnsen, K.4    Lauritzen, T.5    Sandbaek, A.6
  • 22
    • 77955585592 scopus 로고    scopus 로고
    • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial
    • PID: 20594588
    • Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010;376:419–30.
    • (2010) Lancet , vol.376 , pp. 419-430
    • Ismail-Beigi, F.1    Craven, T.2    Banerji, M.A.3    Basile, J.4    Calles, J.5    Cohen, R.M.6
  • 23
    • 0037472879 scopus 로고    scopus 로고
    • Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
    • PID: 12556541
    • Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.
    • (2003) N Engl J Med , vol.348 , pp. 383-393
    • Gaede, P.1    Vedel, P.2    Larsen, N.3    Jensen, G.V.4    Parving, H.H.5    Pedersen, O.6
  • 24
    • 84891859727 scopus 로고    scopus 로고
    • Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort
    • COI: 1:CAS:528:DC%2BC3sXhs1ylt7fF, PID: 23757426, Discusses the BARI 2D trial and its findings
    • Pop-Busui R, Lu J, Brooks MM, Albert S, Althouse AD, Escobedo J, et al. Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort. Diabetes Care. 2013;36:3208–15. Discusses the BARI 2D trial and its findings.
    • (2013) Diabetes Care , vol.36 , pp. 3208-3215
    • Pop-Busui, R.1    Lu, J.2    Brooks, M.M.3    Albert, S.4    Althouse, A.D.5    Escobedo, J.6
  • 25
    • 0032958316 scopus 로고    scopus 로고
    • Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort
    • Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort. Diabetes Care. 1999;22:99–111.
    • (1999) Diabetes Care , vol.22 , pp. 99-111
  • 26
    • 84892425163 scopus 로고    scopus 로고
    • Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study
    • COI: 1:CAS:528:DC%2BC2cXjt1yrtbw%3D, PID: 24356595, Discusses neuropathy and related findings in the DCCT
    • Martin CL, Albers JW, Pop-Busui R. Neuropathy and related findings in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes Care. 2014;37:31–8. Discusses neuropathy and related findings in the DCCT.
    • (2014) Diabetes Care , vol.37 , pp. 31-38
    • Martin, C.L.1    Albers, J.W.2    Pop-Busui, R.3
  • 27
    • 77956394914 scopus 로고    scopus 로고
    • DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history
    • PID: 20464532
    • Pop-Busui R, Herman WH, Feldman EL, Low PA, Martin CL, Cleary PA, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. 2010;10:276–82.
    • (2010) Curr Diab Rep , vol.10 , pp. 276-282
    • Pop-Busui, R.1    Herman, W.H.2    Feldman, E.L.3    Low, P.A.4    Martin, C.L.5    Cleary, P.A.6
  • 28
    • 33645700675 scopus 로고    scopus 로고
    • Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion
    • PID: 16443884
    • Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care. 2006;29:340–4.
    • (2006) Diabetes Care , vol.29 , pp. 340-344
    • Martin, C.L.1    Albers, J.2    Herman, W.H.3    Cleary, P.4    Waberski, B.5    Greene, D.A.6
  • 29
    • 79951715424 scopus 로고    scopus 로고
    • Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study
    • PID: 20833868
    • Martin CL, Waberski BH, Pop-Busui R, Cleary PA, Catton S, Albers JW, et al. Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. Diabetes Care. 2010;33:2635–41.
    • (2010) Diabetes Care , vol.33 , pp. 2635-2641
    • Martin, C.L.1    Waberski, B.H.2    Pop-Busui, R.3    Cleary, P.A.4    Catton, S.5    Albers, J.W.6
  • 30
    • 0028077808 scopus 로고
    • A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy
    • COI: 1:STN:280:DyaK2M7itFWmtw%3D%3D, PID: 7821168
    • Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care. 1994;17:1281–9.
    • (1994) Diabetes Care , vol.17 , pp. 1281-1289
    • Feldman, E.L.1    Stevens, M.J.2    Thomas, P.K.3    Brown, M.B.4    Canal, N.5    Greene, D.A.6
  • 31
    • 84862689585 scopus 로고    scopus 로고
    • Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications
    • COI: 1:STN:280:DC%2BC38vmslGhug%3D%3D, PID: 22417277
    • Herman WH, Pop-Busui R, Braffett BH, Martin CL, Cleary PA, Albers JW, et al. Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabet Med. 2012;29:937–44.
    • (2012) Diabet Med , vol.29 , pp. 937-944
    • Herman, W.H.1    Pop-Busui, R.2    Braffett, B.H.3    Martin, C.L.4    Cleary, P.A.5    Albers, J.W.6
  • 32
    • 0022456070 scopus 로고
    • Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis
    • COI: 1:STN:280:DyaL2s%2FhsFalsQ%3D%3D, PID: 3762934
    • Dyck PJ, Karnes J, O'Brien PC, Swanson CJ. Neuropathy Symptom Profile in health, motor neuron disease, diabetic neuropathy, and amyloidosis. Neurology. 1986;36:1300–8.
    • (1986) Neurology , vol.36 , pp. 1300-1308
    • Dyck, P.J.1    Karnes, J.2    O'Brien, P.C.3    Swanson, C.J.4
  • 33
    • 0026764627 scopus 로고
    • The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity
    • COI: 1:STN:280:DyaK383ptlGgtA%3D%3D, PID: 1603343
    • Dyck PJ, Karnes JL, O'Brien PC, Litchy WJ, Low PA, Melton 3rd LJ. The Rochester Diabetic Neuropathy Study: reassessment of tests and criteria for diagnosis and staged severity. Neurology. 1992;42:1164–70.
    • (1992) Neurology , vol.42 , pp. 1164-1170
    • Dyck, P.J.1    Karnes, J.L.2    O'Brien, P.C.3    Litchy, W.J.4    Low, P.A.5    Melton, L.J.6
  • 35
    • 35148891198 scopus 로고    scopus 로고
    • Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity
    • PID: 17513707
    • Dyck PJ, Norell JE, Tritschler H, Schuette K, Samigullin R, Ziegler D, et al. Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity. Diabetes Care. 2007;30:2619–25.
    • (2007) Diabetes Care , vol.30 , pp. 2619-2625
    • Dyck, P.J.1    Norell, J.E.2    Tritschler, H.3    Schuette, K.4    Samigullin, R.5    Ziegler, D.6
  • 36
    • 84871246506 scopus 로고    scopus 로고
    • Unequivocally Abnormal” vs “Usual” Signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial
    • PID: 22986424
    • Dyck PJ, Overland CJ, Low PA, Litchy WJ, Davies JL, Carter RE, et al. “Unequivocally Abnormal” vs “Usual” Signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial. Arch Neurol. 2012;69:1609–14.
    • (2012) Arch Neurol , vol.69 , pp. 1609-1614
    • Dyck, P.J.1    Overland, C.J.2    Low, P.A.3    Litchy, W.J.4    Davies, J.L.5    Carter, R.E.6
  • 38
  • 39
    • 12944297737 scopus 로고    scopus 로고
    • Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus
    • COI: 1:STN:280:DC%2BD2M%2Fjt1yhug%3D%3D, PID: 15619072
    • Witte DR, Tesfaye S, Chaturvedi N, Eaton SE, Kempler P, Fuller JH. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48:164–71.
    • (2005) Diabetologia , vol.48 , pp. 164-171
    • Witte, D.R.1    Tesfaye, S.2    Chaturvedi, N.3    Eaton, S.E.4    Kempler, P.5    Fuller, J.H.6
  • 40
    • 0031895701 scopus 로고    scopus 로고
    • The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT)
    • DCCT: The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT). Diabetologia. 1998;41:416–23
    • (1998) Diabetologia , vol.41 , pp. 416-423
  • 41
    • 67649497933 scopus 로고    scopus 로고
    • Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC)
    • COI: 1:CAS:528:DC%2BD1MXms1alsLk%3D, PID: 19470886
    • Pop-Busui R, Low PA, Waberski BH, Martin CL, Albers JW, Feldman EL, et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119:2886–93.
    • (2009) Circulation , vol.119 , pp. 2886-2893
    • Pop-Busui, R.1    Low, P.A.2    Waberski, B.H.3    Martin, C.L.4    Albers, J.W.5    Feldman, E.L.6
  • 42
    • 0030731965 scopus 로고    scopus 로고
    • Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects
    • COI: 1:STN:280:DyaK1c%2FltFSgtw%3D%3D, PID: 9390669
    • Low PA, Denq JC, Opfer-Gehrking TL, Dyck PJ, O'Brien PC, Slezak JM. Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects. Muscle Nerve. 1997;20:1561–8.
    • (1997) Muscle Nerve , vol.20 , pp. 1561-1568
    • Low, P.A.1    Denq, J.C.2    Opfer-Gehrking, T.L.3    Dyck, P.J.4    O'Brien, P.C.5    Slezak, J.M.6
  • 43
    • 80053593410 scopus 로고    scopus 로고
    • Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
    • Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:639–53.
    • (2011) Diabetes Metab Res Rev , vol.27 , pp. 639-653
    • Spallone, V.1    Ziegler, D.2    Freeman, R.3    Bernardi, L.4    Frontoni, S.5    Pop-Busui, R.6
  • 44
    • 18744412089 scopus 로고    scopus 로고
    • Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study
    • COI: 1:STN:280:DC%2BD38npvVGmtw%3D%3D, PID: 12421426
    • Kempler P, Tesfaye S, Chaturvedi N, Stevens LK, Webb DJ, Eaton S, et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM Complications Study. Diabet Med. 2002;19:900–9.
    • (2002) Diabet Med , vol.19 , pp. 900-909
    • Kempler, P.1    Tesfaye, S.2    Chaturvedi, N.3    Stevens, L.K.4    Webb, D.J.5    Eaton, S.6
  • 45
    • 77956582081 scopus 로고    scopus 로고
    • Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • COI: 1:CAS:528:DC%2BC3cXpslKgsro%3D, PID: 20215456
    • Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33:1578–84.
    • (2010) Diabetes Care , vol.33 , pp. 1578-1584
    • Pop-Busui, R.1    Evans, G.W.2    Gerstein, H.C.3    Fonseca, V.4    Fleg, J.L.5    Hoogwerf, B.J.6
  • 46
    • 33745290289 scopus 로고    scopus 로고
    • The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience
    • COI: 1:CAS:528:DC%2BD28XksFahtbY%3D, PID: 16644706
    • Pambianco G, Costacou T, Ellis D, Becker DJ, Klein R, Orchard TJ. The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience. Diabetes. 2006;55:1463–9.
    • (2006) Diabetes , vol.55 , pp. 1463-1469
    • Pambianco, G.1    Costacou, T.2    Ellis, D.3    Becker, D.J.4    Klein, R.5    Orchard, T.J.6
  • 47
    • 84892404662 scopus 로고    scopus 로고
    • The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the “gift” that keeps on giving!
    • PID: 24356590
    • Cefalu WT, Ratner RE. The diabetes control and complications trial/epidemiology of diabetes interventions and complications study at 30 years: the “gift” that keeps on giving! Diabetes Care. 2014;37:5–7.
    • (2014) Diabetes Care , vol.37 , pp. 5-7
    • Cefalu, W.T.1    Ratner, R.E.2
  • 48
    • 35148833511 scopus 로고    scopus 로고
    • Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy?
    • PID: 17644617
    • Albers JW, Herman WH, Pop-Busui R, Martin CL, Cleary P, Waberski B. Subclinical neuropathy among Diabetes Control and Complications Trial participants without diagnosable neuropathy at trial completion: possible predictors of incident neuropathy? Diabetes Care. 2007;30:2613–8.
    • (2007) Diabetes Care , vol.30 , pp. 2613-2618
    • Albers, J.W.1    Herman, W.H.2    Pop-Busui, R.3    Martin, C.L.4    Cleary, P.5    Waberski, B.6
  • 49
    • 0034628425 scopus 로고    scopus 로고
    • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group
    • Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med. 2000;342:381–9.
    • (2000) N Engl J Med , vol.342 , pp. 381-389
  • 50
    • 0037093012 scopus 로고    scopus 로고
    • Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
    • DCCT: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA. 2002;287:2563–9.
    • (2002) JAMA , vol.287 , pp. 2563-2569
  • 51
    • 0142087597 scopus 로고    scopus 로고
    • Writing, Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study
    • DCCT/EDIC, Writing, Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003;290:2159–67.
    • (2003) JAMA , vol.290 , pp. 2159-2167
  • 52
    • 29144453326 scopus 로고    scopus 로고
    • Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
    • PID: 16371630
    • Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.
    • (2005) N Engl J Med , vol.353 , pp. 2643-2653
    • Nathan, D.M.1    Cleary, P.A.2    Backlund, J.Y.3    Genuth, S.M.4    Lachin, J.M.5    Orchard, T.J.6
  • 53
    • 77958162719 scopus 로고    scopus 로고
    • Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study
    • PID: 20357373
    • Perkins BA, Orszag A, Ngo M, Ng E, New P, Bril V. Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study. Diabetes Care. 2010;33:1549–54.
    • (2010) Diabetes Care , vol.33 , pp. 1549-1554
    • Perkins, B.A.1    Orszag, A.2    Ngo, M.3    Ng, E.4    New, P.5    Bril, V.6
  • 54
    • 53749096863 scopus 로고    scopus 로고
    • 10-year follow-up of intensive glucose control in type 2 diabetes
    • COI: 1:CAS:528:DC%2BD1cXht1Wgt7nK, PID: 18784090
    • Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.
    • (2008) N Engl J Med , vol.359 , pp. 1577-1589
    • Holman, R.R.1    Paul, S.K.2    Bethel, M.A.3    Matthews, D.R.4    Neil, H.A.5
  • 55
    • 84871559675 scopus 로고    scopus 로고
    • Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study
    • COI: 1:STN:280:DC%2BC3s%2FltVaiuw%3D%3D, PID: 23064291
    • Charles M, Fleischer J, Witte DR, Ejskjaer N, Borch-Johnsen K, Lauritzen T, et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia. 2013;56:101–8.
    • (2013) Diabetologia , vol.56 , pp. 101-108
    • Charles, M.1    Fleischer, J.2    Witte, D.R.3    Ejskjaer, N.4    Borch-Johnsen, K.5    Lauritzen, T.6
  • 57
    • 77953069181 scopus 로고    scopus 로고
    • Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • PID: 20103550
    • Calles-Escandon J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, et al. Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care. 2010;33:721–7.
    • (2010) Diabetes Care , vol.33 , pp. 721-727
    • Calles-Escandon, J.1    Lovato, L.C.2    Simons-Morton, D.G.3    Kendall, D.M.4    Pop-Busui, R.5    Cohen, R.M.6
  • 58
    • 84866324862 scopus 로고    scopus 로고
    • Enhanced glucose control for preventing and treating diabetic neuropathy
    • PID: 22696371, Discusses how to prevent and treat diabetic neuropathy with enhanced glucose control
    • Callaghan BC, Little AA, Feldman EL, Hughes RA. Enhanced glucose control for preventing and treating diabetic neuropathy. Cochrane Database Syst Rev. 2012;6:CD007543. Discusses how to prevent and treat diabetic neuropathy with enhanced glucose control.
    • (2012) Cochrane Database Syst Rev , vol.6 , pp. CD007543
    • Callaghan, B.C.1    Little, A.A.2    Feldman, E.L.3    Hughes, R.A.4
  • 59
    • 67149142042 scopus 로고    scopus 로고
    • A randomized trial of therapies for type 2 diabetes and coronary artery disease
    • COI: 1:CAS:528:DC%2BD1MXntVKqtrw%3D, PID: 19502645
    • Frye RL, August P, Brooks MM, Hardison RM, Kelsey SF, MacGregor JM, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360:2503–15.
    • (2009) N Engl J Med , vol.360 , pp. 2503-2515
    • Frye, R.L.1    August, P.2    Brooks, M.M.3    Hardison, R.M.4    Kelsey, S.F.5    MacGregor, J.M.6
  • 60
    • 80053607473 scopus 로고    scopus 로고
    • Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management
    • Kempler P, Amarenco G, Freeman R, Frontoni S, Horowitz M, Stevens M, et al. Gastrointestinal autonomic neuropathy, erectile-, bladder- and sudomotor dysfunction in patients with diabetes mellitus: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27:665–77.
    • (2011) Diabetes Metab Res Rev , vol.27 , pp. 665-677
    • Kempler, P.1    Amarenco, G.2    Freeman, R.3    Frontoni, S.4    Horowitz, M.5    Stevens, M.6
  • 61
    • 0029994187 scopus 로고    scopus 로고
    • Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
    • COI: 1:CAS:528:DyaK28XmvFCjt7w%3D, PID: 8933008
    • Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al. Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study. Diabetologia. 1996;39:1377–84.
    • (1996) Diabetologia , vol.39 , pp. 1377-1384
    • Tesfaye, S.1    Stevens, L.K.2    Stephenson, J.M.3    Fuller, J.H.4    Plater, M.5    Ionescu-Tirgoviste, C.6
  • 62
    • 0041668049 scopus 로고    scopus 로고
    • The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis
    • PID: 12766130
    • Maser RE, Mitchell BD, Vinik AI, Freeman R. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care. 2003;26:1895–901.
    • (2003) Diabetes Care , vol.26 , pp. 1895-1901
    • Maser, R.E.1    Mitchell, B.D.2    Vinik, A.I.3    Freeman, R.4
  • 63
    • 84866076600 scopus 로고    scopus 로고
    • What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes
    • PID: 22644723
    • Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res. 2012;5:463–78.
    • (2012) J Cardiovasc Transl Res , vol.5 , pp. 463-478
    • Pop-Busui, R.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.